Antibody Engineering, Phage Display & Immune Repertoire Analysis (CANCELED)
October 14 - 28, 2020
Application Deadline: July 15, 2020
Gregg Silverman, New York University School of Medicine
Christoph Rader, Scripps Research Institute
Gianluca Veggiani, Universtiy of Toronto
COVID-19: UPDATE May 25, 2020: It is with considerable regret that we announce the cancellation of this course for 2020 but it will be rescheduled to similar dates in 2021.
See the roll of honor - who's taken the course in the past
Advances in the generation and selection of antibodies from combinatorial libraries allow for the rapid production of antibodies from immune and non-immune sources. This intensive laboratory/lecture course will focus on the construction of combinatorial antibody libraries expressed on the surface of filamentous phage and the subsequent selection of desired antibodies from the library. Students will learn the theoretical and practical aspects of constructing combinatorial libraries from immune and non-immune sources as well as the construction of synthetic antibody libraries. Antigen-specific recombinant monoclonal antibodies will be selected from the library. Production, purification and characterization of antibody fragments expressed in E. coli will also be covered.
The lecture series, presented by course faculty and a number of invited speakers, will emphasize theory and practice of antibody display technologies, expression of antibodies in E. coli and mammalian cells, antibody structure and function, bacterial display of antibodies and other ligand-binding domains, the immunobiology of the antibody response, and the use of monoclonal antibodies for therapy including the design of chimeric antigen receptor T cells. We will also discuss principles and protocols for generation and analysis of immune repertoires determined by Next Generation Sequencing.
2019 Speakers included:
Donald Siegel, University of Pennsylvania
Sachdev Sidhu, University of Toronto
Brandon Dekosky, Kansas University
Shohei Koide, New York University
Stefan Stahl, Royal Swedish Institute (KTH)
Birgit Dreier, University of Zurich
Mary Ann Pohl, Tri-Institutional Therapeutics Discovery Institute
This course is supported with funds provided by: National Institute of General Medical Sciences.
We would like to acknowledge the following companies that provided invaluable support:
Equipment: Thermo Fisher Scientific
Support & Stipends
Stipends are available to offset tuition costs as follows:
US applicants (National Institute of General Medical Sciences)
Interdisciplinary Fellowships (transitioning from outside biology) & Scholarships (transitioning from other biological disciplines) (Helmsley Charitable Trust)
International applicants (Howard Hughes Medical Institute)
Please indicate your eligibility for funding in your stipend request submitted when you apply to the course. Stipend requests do not affect selection decisions made by the instructors.
Students accepted into the course should plan to arrive by early evening on October 13 and plan to depart after lunch on October 28.